ENDPOINTS NEWS15h
Post-Hoc: Big Phar­ma is los­ing the AI tal­ent war
NeurIPS, the biggest AI research conference, turned Vancouver’s convention center into a battleground for wooing AI talent.
ENDPOINTS NEWS18h
DNA ed­it leads to ap­par­ent cure in in­fant; CDER di­rec­tor to step down; More biotechs emerge with as­sets from Chi­na; and more
Endpoints Weekly reports on iECURE's gene therapy success for OTC deficiency, FDA CDER director Patrizia Cavazzoni's departure, and Verdiva Bio's $411M launch with Sciwind assets.